Probius DX

BiotechnologySeries AFremont, USprobius.bio

Latest round

Series A

Last raised

Dec 2020

Total raised

$2.5M

Investors

9

About Probius DX

Based in California, US, and founded in 2016, Probius DX Inc. operates as a biotechnology company that uses artificial intelligence and biology data for biological research and decentralized predictive healthcare. The company was Co-founded by Emmanuel Quevy (CEO), Roger Howe, and Chaitanya Gupta (CTO). In December 2020, Probius DX, Inc. The firm offers bioanalytical technology called QES which is combined with artificial intelligence and provides predictive insights into diseases which helps in drug development. The MiniQES bioanalytical platform offered by the firm collects bioanalytical data through MiniQES reader which is an internet of things-based standalone benchtop device, a QES disposable vial that contains sensors that enable quantum electrochemistry, and a bioanalytical cloud service that provides sample classification, biomarker discovery, and analyte quantitation.

Who invested in Probius DX

9 investors across 2 rounds

See all investors in Probius DX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 1, 2020

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    Jun 1, 2018

    Amount

    $2.5M

    Investors

    Locked

Questions about Probius DX

Who invested in Probius DX?

Probius DX has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Probius DX raised?

Probius DX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Probius DX last raise money?

Probius DX's most recent round on record is a Series A, in Dec 2020.

What does Probius DX do?

Based in California, US, and founded in 2016, Probius DX Inc.

Where is Probius DX headquartered?

Probius DX is headquartered in Fremont, US.

Which VCs invest in companies like Probius DX?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Probius DX's stage. Their profiles are linked below.

Raising like Probius DX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.